CARAMORI, GAETANO
 Distribuzione geografica
Continente #
AS - Asia 430
NA - Nord America 146
EU - Europa 29
SA - Sud America 4
AF - Africa 3
Totale 612
Nazione #
SG - Singapore 359
US - Stati Uniti d'America 144
CN - Cina 50
IT - Italia 18
IR - Iran 9
JP - Giappone 8
BR - Brasile 4
CI - Costa d'Avorio 3
TH - Thailandia 3
IE - Irlanda 2
MX - Messico 2
NL - Olanda 2
RU - Federazione Russa 2
BE - Belgio 1
DE - Germania 1
HK - Hong Kong 1
PL - Polonia 1
RO - Romania 1
UA - Ucraina 1
Totale 612
Città #
Singapore 196
Los Angeles 73
Shanghai 31
Ashburn 14
New York 10
Tokyo 8
Forest City 5
Phoenix 5
Ribeirão Preto 4
Abidjan 3
Podenzana 3
Santa Clara 3
Bangkok 2
Boardman 2
Dublin 2
Naples 2
Prato 2
Schwenksville 2
West Jordan 2
Xochimilco 2
Agawam 1
Brescia 1
Chachoengsao 1
Clifton 1
Council Bluffs 1
Eboli 1
Ferrara 1
Genoa 1
Ghent 1
Hong Kong 1
Irving 1
Moscow 1
Nuremberg 1
Pontedera 1
San Ferdinando di Puglia 1
Sebeş 1
Siziano 1
Totale 388
Nome #
Mechanisms of respiratory virus-induced asthma exacerbations 18
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare 15
Differential expression of RNA-binding proteins in airway epithelium in chronic lung inflammation 12
Immunomodulatory effect of gefitinib in epidermal growth factor receptor tyrosine kinase inhibitors sensitive and resistant Non small cell lung cancer: role of the RNA binding protein HuR 11
Transcription Factors 11
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 10
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive 9
Delivery systems e protocollo di Montreal 7
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 6
Allergen Responses Modified by a GATA3 DNAzyme 6
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 6
Controversie in tema di terapia dell’asma e della BPCO 6
Overlap and common correlates between depression and COPD: a narrative review 6
Airway obstruction in chronic obstructive pulmonary disease 6
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression 6
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 5
Anatomia e fisiologia clinica della pleura 5
Ultrasound for assessment of diaphragm function in late-onset Pompe disease 5
Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature 5
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 5
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 5
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 4
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 4
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 4
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 4
Posttranscriptional regulation of airway epithelial responses by the RNA binding protein AUF-1 4
New targets for drug development in asthma 4
Transcription Factors 4
Oxidants and asthma 4
Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease 4
Degree of control of physician-diagnosed asthma and COPD in Italy 4
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase 4
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO) 4
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 4
Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD 4
Scavenger receptor B1 involvement in chronic obstructive pulmonary disease pathogenesis 4
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 4
RNA-Binding Proteins as a Molecular Link between COPD and Lung Cancer 4
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension 4
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 4
RNA-binding Proteins as a New Link Between COPD and Lung Cancer 4
Fattori genetici nell’asma e nella BPCO 4
Activation of NF-kappaB transcription factor in asthma death 4
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 4
Anti-inflammatory treatments for asthma: past, present, future 4
La scoperta dell’ossido nitrico endogeno ha aperto nuove prospettive terapeutiche nella patologia polmonare dell’adulto? 4
Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation 4
A link between lung injury and inflammatory myopathies: making the diagnosis 4
An unusual cause of dyspnoea in a patient with chronic ischemic heart disease 4
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 4
Broncodilatatori nella terapia delle broncopneumopatie croniche ostruttive 3
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 3
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? 3
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 3
Sintesi delle nuove linee guida internazionali per la terapia farmacologica dell’asma 3
Role of the mucins in pathogenesis of COPD: implications for therapy 3
Role of oxidative stress in the pathogenesis of COPD 3
Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease 3
Increased deposition of activated complement in peripheral lung vessels of smokers 3
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes 3
Telithromycin in acute exacerbations of asthma 3
A case of fibrosing interstitial pneumonia 3
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 3
Effect of acute and chronic inflammatory stimuli on expression of protease-activated receptors 1 and 2 in alveolar macrophages 3
Polmoniti da parassiti (parte 1) 3
Asthma: a chronic infectious disease? 3
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview 3
Retraction Note: The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide (Respiratory Research, (2018), 19, 1, (85), 10.1186/s12931-018-0788-x) 3
Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages 3
Breaking news: DNA damage and repair pathways in COPD and implications for pathogenesis and treatment 3
Interferonopathy: A potential link between innate immunity and autoimmunity in the pathogenesis of COPD 3
Corticosteroids: basic pharmacology 3
Malattie della pleura 3
OXIDANTS AND ANTIOXIDANTS | Antioxidants, Nonenzymatic 3
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione 3
Bronchial glomus tumor mimicking a COPD exacerbation 3
Expiratory flow limitation as a risk factor for pulmonary complications after major abdominal surgery 3
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia 3
Ipertensione polmonare cronica nell’adulto 3
La teofillina nell’asma e nella BPCO: nuove prospettive (2° parte) 3
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease 3
CORTICOSTEROIDS | Glucocorticoid Receptors 3
The level of control of mild asthma in general practice: an observational community-based study 3
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 3
The complexity of asthma phenotype 3
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance 3
Ruolo delle infezioni respiratorie nelle riacutizzazioni di BPCO [Role of respiratory infections in COPD exacerbations] 3
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 3
Near-fatal asthma phenotype in the ENFUMOSA Cohort 3
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation 3
Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study 3
La terapia farmacologica dell’asma nei prossimi cinque anni: l’opinione dello specialista 3
Definizione e basi biologiche della broncopneumopatia cronica ostruttiva 3
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology 3
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 3
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 3
Poxviridae Pneumonia 3
Endobronchial metastases of renal cell carcinoma: a complex multidisciplinary treatment 3
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 3
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease 3
Totale 431
Categoria #
all - tutte 13.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024948 0 0 0 0 345 30 43 6 21 99 104 300
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 962